2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$3.55-$0.03 (-0.81%)
Price as of Nov 12, 2026 7:39 AM EST- $450.0MMarket Cap
- -35.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$3.55-$0.03 (-0.81%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.58 | ||
Change | +$0.06 (+1.70%) | ||
Open | $3.56 | ||
High | $3.73 | ||
Low | $3.54 | ||
Previous Close | $3.52 | ||
Volume | 2,179,689 | ||
30-Day Average Volume | 2,541,296 | ||
1-Week Change | -5.79% | ||
1-Month Change | -25.10% | ||
1-Year Change | -35.84% | ||
3-Year Change | 113.10% | ||
5-Year Change | -41.79% | ||
Fundamentals | |||
Shares Outstanding | 125.7M | ||
Total Assets | $119.3M | ||
Market Cap | $450.0M | ||
Enterprise Value | $410.4M | ||
Period: QTR TTM FY | |||
Revenue | $7.6M | ||
Net Income | -$16.5M | ||
Free Cash Flow | -$7.6M | ||
EBIT | -$16.5M | ||
EBITDA | -$16.3M | ||
Net Working Capital | $88.5M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 54 | ||
P/B | -6 | ||
P/E | -28 | ||
PEG | -1 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue